All proposals of the Board of Directors approvedSeverin Schwan elected as new Chairman of the Board of Directors; all other members of the Board of Directors standing for election were electedThomas Schinecker
Recent advances in cancer genomics have deepened the medical community's understanding of the molecular alterations in brain tumours, more precisely subclassifying patients into specific diagnoses. Understanding
Basel, 10 February 2023 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the Roche Long Term Foundation acquired 540'000 Roche bearer shares at the price determined via an accelerated book building
Vabysmo met its primary endpoint in two clinical trials, BALATON and COMINO, showing non-inferior visual acuity gains compared to afliberceptMore Vabysmo patients showed an absence of blood vessel leakage